IP Library Granted Patent US 7,049,111
Granted Patent B1
US 7,049,111 · App. 09/869,334 · Granted May 23, 2006

Process for producing HMG-CoA reductase inhibitor

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,049,111
App. No.
09/869,334
Granted
May 23, 2006
Kind
B1
Abstract

The present invention relates to a protein derived from a microorganism belonging to the genus Bacillus , which has an activity of hydroxylating a compound represented by the formula (I-a): wherein R 1 represents a hydrogen atom, a substituted or unsubstituted alkyl, or an alkali metal, and R 2 represents a substituted or unsubstituted alkyl or a substituted or unsubstituted aryl, or a ring-closed lactone form thereof; a DNA encoding the protein; and a recombinant DNA comprising the DNA.

Claims (67)

1. An isolated DNA having the nucleotide sequence shown by SEQ ID NO: 2.

2. A recombinant DNA vector comprising the DNA according to claim 1 .

3. An isolated transformed cell obtained by introducing the recombinant DNA vector according to claim 2 into a host cell.

4. The transformed cell according to claim 3 wherein the transformed cell belongs to a microorganism selected from the genera Escherichia, Bacillus, Corynebacterium , and Streptomyces.

5. The transformed cell according to claim 3 wherein the transformed cell belongs to microorganism selected from Escherichia coli, Bacillus subtilis, Bacillus megaterium, Corynebacterium glutamicum, Corynebacterium ammoniagenes, Corynebacterium callunae and Streptomyces lividans.

6. A process for producing compound (II-a) or compound (II-b), wherein The transformed cell according to claim 3 , a culture of the transformed cell, or a treated product of the culture is used as an enzyme source, and the process comprises:

allowing compound (I-a) or compound (I-b) to exist in an aqueous medium in the presence of the enzyme source;

allowing compound (II-a) or compound (II-b) to be produced and accumulated in said aqueous medium; and

collecting compound (II-a) or compound (II-b) from said aqueous medium wherein, the compound (I-a) is a compound represented by the formula (I-a):

the compound (I-b) is a lactone form of compound (I-a) and is represented by the formula (I-b):

the compound (II-a) is a compound represented by the formula (II-a):

the compound (II-b) is a lactone form of compound (II-a) and is represented by the formula (II-b):

and wherein R 1 represents a hydrogen atom, a substituted or unsubstituted alkyl, or an alkali metal, and R 2 represents a substituted or unsubstituted alkyl, or a substituted or unsubstituted aryl; and wherein the treated product of the culture of the transformed cell is a treated product selected from cultured cells, dried cells, freeze-dried cells, cells treated with a surfactant, cells treated with an enzyme, cells treated by ultrasonication, cells treated by mechanical milling, cells treated by solvent, a protein fraction of a cell, and immobilized cells.

7. A process for producing compound (IV-a) or compound (IV-b), wherein the transformed cell according to claim 3 , a culture of the transformed cell, or a treated product of the culture is used as an enzyme source, and the process comprises:

allowing compound (III-a) or compound (III-b) to exist in an aqueous medium in the presence of the enzyme source;

allowing compound (IV-a) or compound (IV-b) to be produced and accumulated in said aqueous medium; and

collecting compound (IV-a) or compound (IV-b) from said aqueous medium wherein, the compound (III-a) is a compound represented by the formula (III-a):

the compound (III-b) is a lactone form of compound (III-a) and is represented by the formula (III-b):

the compound (IV-a) is a compound represented by the formula (IV-a):

the compound (IV-b) is a lactone form of compound (IV-a) and is represented by the formula (IV-b):

and wherein R 1 represents a hydrogen atom, a substituted or unsubstituted alkyl, or an alkali metal, and R 2 represents a substituted or unsubstituted alkyl, or a substituted or unsubstituted aryl; and wherein the treated product of the culture of the transformed cell is a treated product selected from cultured cells, dried cells, freeze-dried cells, cells treated with a surfactant, cells treated with an enzyme, cells treated by ultrasonication, cells treated by mechanical milling, cells treated by solvent, a protein fraction of a cell, and immobilized cells.

8. A process for producing compound (VI-a) or compound (VI-b), wherein the transformed cell according to claim 3 , a culture of the transformed cell, or a treated product of the culture is used as an enzyme source, and the process comprises:

allowing compound (V-a) or compound (V-b) to exist in an aqueous medium in the presence of the enzyme source;

allowing compound (VI-a) or compound (VI-b) to be produced and accumulated in said aqueous medium; and

collecting compound (VI-a) or compound (VI-b) from said aqueous medium wherein, the compound (V-a) is a compound represented by the formula (V-a):

the compound (V-b) is a lactone form of compound (V-a) and is represented by the formula (V-b):

the compound (VI-a) is a compound represented by the formula (VI-a):

the compound (VI-b) is a lactone form of compound (VI-a) and is represented by the formula (VI-b):

and wherein R 1 represents a hydrogen atom, a substituted or unsubstituted alkyl, or an alkali metal; and wherein the treated product of the culture of the transformed cell is a treated product selected from cultured cells, dried cells, freeze-dried cells, cells treated with a surfactant, cells treated with an enzyme, cells treated by ultrasonication, cells treated by mechanical milling, cells treated by solvent, a protein fraction of a cell, and immobilized cells.

9. A process for producing compound (VIII-a) or compound (VIII-b), wherein the transformed cell according to claim 3 , a culture of the transformed cell, or a treated product of the culture is used as an enzyme source, and the process comprises:

allowing compound (VII-a) or compound (VII-b) to exist in an aqueous medium in the presence of the enzyme source;

allowing compound (VII-a) or compound (VII-b) to be produced and accumulated in said aqueous medium; and

collecting compound (VIII-a) or compound (VIII-b) from said aqueous medium wherein, the compound (VII-a) is a compound represented by the formula (VII-a):

the compound (VII-b) is a lactone form of compound (VII-a) and is represented by the formula (VII-b):

the compound (VIII-a) is a compound represented by the formula (VIII-a):

the compound (VII-b) is a lactone form of compound (VIII-a) and is represented by the formula (VIII-b):

and wherein R 1 represents a hydrogen atom, a substituted or unsubstituted alkyl, or an alkali metal; and wherein the treated product of the culture of the transformed cell is a treated product selected from cultured cells, dried cells, freeze-dried cells, cells treated with a surfactant, cells treated with an enzyme, cells treated by ultrasonication, cells treated by mechanical milling, cells treated by solvent, a protein fraction of a cell, and immobilized cells.

10. The process according to claim 6 , wherein the compound (II-b) is obtained by forming a lactone from compound (II-a), the compound (II-a) is a compound represented by the formula (II-a):

the compound (II-b) is a lactone form of compound (II-a) and is represented by the formula (II-b):

and wherein R 1 represents a hydrogen atom, a substituted or unsubstituted alkyl, or an alkali metal, and R 2 represents a substituted or unsubstituted alkyl, or a substituted or unsubstituted aryl.

11. The process according to claim 6 , wherein the compound (II-a) is obtained by opening the lactone ring of compound (II-b), the compound (II-a) is a compound represented by the formula (II-a):

the compound (II-b) is a lactone form of compound (II-a) and is represented by the formula (II-b):

and wherein R 1 represents a hydrogen atom, a substituted or unsubstituted alkyl, or an alkali metal, and R 2 represents a substituted or unsubstituted alkyl, or a substituted or unsubstituted aryl.

12. The process according to claim 7 , wherein the compound (IV-b) is obtained by forming a lactone from compound (IV-a), the compound (IV-a) is a compound represented by the formula (IV-a):

the compound (IV-b) is a lactone form of compound (IV-a) and is represented by the formula (IV-b):

and wherein R 1 represents a hydrogen atom, a substituted or unsubstituted alkyl, or an alkali metal, and R 2 represents a substituted or unsubstituted alkyl, or a substituted or unsubstituted aryl.

13. The process according to claim 7 , wherein the compound (IV-a) is obtained by opening the lactone ring of compound (IV-b), the compound (IV-a) is a compound represented by the formula (IV-a):

the compound (IV-b) is a lactone form of compound (IV-a) and is represented by the formula (IV-b):

and wherein R 1 represents a hydrogen atom, a substituted or unsubstituted alkyl, or an alkali metal, and R 2 represents a substituted or unsubstituted alkyl, or a substituted or unsubstituted aryl.

14. The process according to claim 8 , wherein the compound (VI-b) is obtained by forming a lactone from compound (VI-a), the compound (IV-a) is a compound represented by the formula (IV-a):

the compound (IV-b) is a lactone form of compound (IV-a) and is represented by the formula (IV-b):

and wherein R 1 represents a hydrogen atom, a substituted or unsubstituted alkyl, or an alkali metal, and R 2 represents a substituted or unsubstituted alkyl, or a substituted or unsubstituted aryl.

15. The process according to claim 8 , wherein the compound (VI-a) is obtained by opening the lactone ring of compound (VI-b), the compound (VI-a) is a compound represented by the formula (VI-a):

the compound (VI-b) is a lactone form of compound (VI-a) and is represented by the formula (VI-b):

and wherein R 1 represents a hydrogen atom, a substituted or unsubstituted alkyl, or an alkali metal.

16. The process according to claim 9 , wherein the compound (VIII-b) is obtained by forming a lactone from compound (VIII-a), the compound (VIII-a) is a compound represented by the formula (VIII-a):

the compound (VIII-b) is a lactone form of compound (VIII-a) and is represented by the formula (VIII-b):

and wherein R 1 represents a hydrogen atom, a substituted or unsubstituted alkyl, or an alkali metal.

17. The process according to claim 9 , wherein the compound (VIII-a) is obtained by opening the lactone ring of compound (VIII-b), the compound (VIII-a) is a compound represented by the formula (VIII-a):

the compound (VIII-b) is a lactone form of compound (VIII-a) and is represented by the formula (VIII-b):

and wherein R 1 represents a hydrogen atom, a substituted or unsubstituted alkyl, or an alkali metal.

18. A process for producing a protein, which is derived from a microorganism belonging to the genus Bacillus , and has an activity of producing compound (II-a) or compound (II-b) from compound (I-a) or compound (I-b).

wherein the compound (I-a) is a compound represented by the formula (I-a):

the compound (I-b) is a lactone form of compound (I-a) and is represented by the formula (I-b):

the compound (II-a) is a compound represented by the formula (II-a):

the compound (II-b) is a lactone form of compound (II-a) and is represented by the formula (II-b):

wherein R 1 represents a hydrogen atom, a substituted or unsubstituted alkyl, or an alkali metal, and R 2 represents a substituted or unsubstituted alkyl, or a substituted or unsubstituted aryl, which comprises culturing a transformed cell obtained by introducing a recombinant DNA vector comprising the DNA having the nucleotide sequence shown by SEQ ID NO: 2 in a medium; producing and accumulating the protein in the culture; and collecting the protein from said culture.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 17, 2009
From: KYOWA HAKKO KOGYO CO., LTD.
To: KYOWA HAKKO BIO CO., LTD.
Reel/Frame 022399/0602 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 26, 2001
From: ENDO, HIROFUMI; YONETANI, YOSHIYUKI; MIZOGUCHI, HIROSHI; HASHIMOTO, SHIN-ICHI; OZAKI, AKIO
To: KYOWA HAKKO KOGYO CO., LTD.
Reel/Frame 012206/0781 →